<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39348120</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Tracking COVID-19 Infections Using Survey Data on Rapid At-Home Tests.</ArticleTitle><Pagination><StartPage>e2435442</StartPage><MedlinePgn>e2435442</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2435442</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2024.35442</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Identifying and tracking new infections during an emerging pandemic is crucial to design and deploy interventions to protect populations and mitigate the pandemic's effects, yet it remains a challenging task.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To characterize the ability of nonprobability online surveys to longitudinally estimate the number of COVID-19 infections in the population both in the presence and absence of institutionalized testing.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">Internet-based online nonprobability surveys were conducted among residents aged 18 years or older across 50 US states and the District of Columbia, using the PureSpectrum survey vendor, approximately every 6 weeks between June 1, 2020, and January 31, 2023, for a multiuniversity consortium-the COVID States Project. Surveys collected information on COVID-19 infections with representative state-level quotas applied to balance age, sex, race and ethnicity, and geographic distribution.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">The main outcomes were (1) survey-weighted estimates of new monthly confirmed COVID-19 cases in the US from January 2020 to January 2023 and (2) estimates of uncounted test-confirmed cases from February 1, 2022, to January 1, 2023. These estimates were compared with institutionally reported COVID-19 infections collected by Johns Hopkins University and wastewater viral concentrations for SARS-CoV-2 from Biobot Analytics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The survey spanned 17 waves deployed from June 1, 2020, to January 31, 2023, with a total of 408 515 responses from 306 799 respondents (mean [SD] age, 42.8 [13.0] years; 202 416 women [66.0%]). Overall, 64 946 respondents (15.9%) self-reported a test-confirmed COVID-19 infection. National survey-weighted test-confirmed COVID-19 estimates were strongly correlated with institutionally reported COVID-19 infections (Pearson correlation, r = 0.96; P &lt; .001) from April 2020 to January 2022 (50-state correlation mean [SD] value, r = 0.88 [0.07]). This was before the government-led mass distribution of at-home rapid tests. After January 2022, correlation was diminished and no longer statistically significant (r = 0.55; P = .08; 50-state correlation mean [SD] value, r = 0.48 [0.23]). In contrast, survey COVID-19 estimates correlated highly with SARS-CoV-2 viral concentrations in wastewater both before (r = 0.92; P &lt; .001) and after (r = 0.89; P &lt; .001) January 2022. Institutionally reported COVID-19 cases correlated (r = 0.79; P &lt; .001) with wastewater viral concentrations before January 2022, but poorly (r = 0.31; P = .35) after, suggesting that both survey and wastewater estimates may have better captured test-confirmed COVID-19 infections after January 2022. Consistent correlation patterns were observed at the state level. Based on national-level survey estimates, approximately 54 million COVID-19 cases were likely unaccounted for in official records between January 2022 and January 2023.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">This study suggests that nonprobability survey data can be used to estimate the temporal evolution of test-confirmed infections during an emerging disease outbreak. Self-reporting tools may enable government and health care officials to implement accessible and affordable at-home testing for efficient infection monitoring in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santillana</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Machine Intelligence Group for the Betterment of Health and the Environment, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Cambridge, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Science Institute, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uslu</LastName><ForeName>Ata A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Network Science Institute, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urmi</LastName><ForeName>Tamanna</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Machine Intelligence Group for the Betterment of Health and the Environment, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Science Institute, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintana-Mathe</LastName><ForeName>Alexi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Network Science Institute, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Druckman</LastName><ForeName>James N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Political Science, University of Rochester, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ognyanova</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Communication and Information, Rutgers University, New Brunswick, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baum</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Government, John F. Kennedy School of Government, Harvard University, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perlis</LastName><ForeName>Roy H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Editor, JAMA Network Open.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazer</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Network Science Institute, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Political Science, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Khoury College of Computer Sciences, Northeastern University, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Quantitative Social Science, Harvard University, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1001/jamanetworkopen.2024.35407</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Santillana reported receiving institutional research funds from the Johnson &amp; Johnson Foundation, Janssen Global Public Health, and Pfizer Pharmaceuticals Inc. Drs Ognyanova and Baum reported receiving grants from the National Science Foundation during the conduct of the study. Dr Perlis reported receiving personal fees from Vault Health, Genomind, Circular Genomics, Psy Therapeutics, Swan AI Studios, and Belle outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39348120</ArticleId><ArticleId IdType="pmc">PMC11443354</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.35442</ArticleId><ArticleId IdType="pii">2824211</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lipsitch M, Santillana M. Enhancing situational awareness to prevent infectious disease outbreaks from becoming catastrophic. Curr Top Microbiol Immunol. 2019;424:59-74. doi:10.1007/82_2019_172</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/82_2019_172</ArticleId><ArticleId IdType="pubmed">31292726</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell TW, Golding N, Hellewell J, et al. ; CMMID COVID-19 working group . Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. BMC Med. 2020;18(1):332. doi:10.1186/s12916-020-01790-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01790-9</ArticleId><ArticleId IdType="pmc">PMC7577796</ArticleId><ArticleId IdType="pubmed">33087179</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown TS, Walensky RP. Serosurveillance and the COVID-19 epidemic in the US: undetected, uncertain, and out of control. JAMA. 2020;324(8):749-751. doi:10.1001/jama.2020.14017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.14017</ArticleId><ArticleId IdType="pubmed">32692350</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. COVID data tracker: COVID-19 update for the United States. Published November 20, 2023. Accessed November 21, 2023. https://covid.cdc.gov/covid-data-tracker/#datatracker-home</Citation></Reference><Reference><Citation>Lu FS, Nguyen AT, Link NB, et al. . Estimating the cumulative incidence of COVID-19 in the United States using influenza surveillance, virologic testing, and mortality data: four complementary approaches. PLoS Comput Biol. 2021;17(6):e1008994. doi:10.1371/journal.pcbi.1008994</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008994</ArticleId><ArticleId IdType="pmc">PMC8241061</ArticleId><ArticleId IdType="pubmed">34138845</ArticleId></ArticleIdList></Reference><Reference><Citation>The COVID States Project. The decision to not get vaccinated, from the perspective of the unvaccinated. Accessed May 20, 2024. https://www.covidstates.org/reports/the-decision-to-not-get-vaccinated-from-the-perspective-of-the-unvaccinated</Citation></Reference><Reference><Citation>Mina MJ, Andersen KG. COVID-19 testing: one size does not fit all. Science. 2021;371(6525):126-127. doi:10.1126/science.abe9187</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe9187</ArticleId><ArticleId IdType="pubmed">33414210</ArticleId></ArticleIdList></Reference><Reference><Citation>Velavan TP, Meyer CG. COVID-19: a PCR-defined pandemic. Int J Infect Dis. 2021;103:278-279. doi:10.1016/j.ijid.2020.11.189</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.189</ArticleId><ArticleId IdType="pmc">PMC7704340</ArticleId><ArticleId IdType="pubmed">33271291</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. COVID data tracker. Published online March 2020. Accessed December 15, 2023. https://covid.cdc.gov/COVID-data-tracker/</Citation></Reference><Reference><Citation>Yamayoshi S, Sakai-Tagawa Y, Koga M, et al. . Comparison of rapid antigen tests for COVID-19. Viruses. 2020;12(12):1420. doi:10.3390/v12121420</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12121420</ArticleId><ArticleId IdType="pmc">PMC7764512</ArticleId><ArticleId IdType="pubmed">33322035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby AE, Walters MS, Jennings WC, et al. . Using wastewater surveillance data to support the COVID-19 response—United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1242-1244. doi:10.15585/mmwr.mm7036a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7036a2</ArticleId><ArticleId IdType="pmc">PMC8437053</ArticleId><ArticleId IdType="pubmed">34499630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Xiao A, Zhang J, et al. . SARS-CoV-2 RNA concentrations in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases. Sci Total Environ. 2022;805:150121. doi:10.1016/j.scitotenv.2021.150121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2021.150121</ArticleId><ArticleId IdType="pmc">PMC8416286</ArticleId><ArticleId IdType="pubmed">34534872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaashoek J, Santillana M. COVID-19 positive cases, evidence on the time evolution of the epidemic or an indicator of local testing capabilities? a case study in the United States. Published online April 10, 2020. Accessed December 15, 2023. doi:10.2139/ssrn.3574849</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3574849</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. The United States badly bungled coronavirus testing—but things may soon improve. Science. Published online February 28, 2020. Accessed December 15, 2023. https://www.science.org/content/article/united-states-badly-bungled-coronavirus-testing-things-may-soon-improve</Citation></Reference><Reference><Citation>Blavatnik School of Government, University of Oxford. COVID-19 government response tracker. Accessed November 3, 2022. https://www.bsg.ox.ac.uk/research/covid-19-government-response-tracker</Citation></Reference><Reference><Citation>Taube JC, Susswein Z, Bansal S. Spatiotemporal trends in self-reported mask-wearing behavior in the United States: analysis of a large cross-sectional survey. JMIR Public Health Surveill. 2023;9:e42128. doi:10.2196/42128</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/42128</ArticleId><ArticleId IdType="pmc">PMC10028521</ArticleId><ArticleId IdType="pubmed">36877548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok KO, Li KK, Wei WI, Tang A, Wong SYS, Lee SS. Editor’s choice: influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey. Int J Nurs Stud. 2021;114:103854. doi:10.1016/j.ijnurstu.2020.103854</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2020.103854</ArticleId><ArticleId IdType="pmc">PMC7831770</ArticleId><ArticleId IdType="pubmed">33326864</ArticleId></ArticleIdList></Reference><Reference><Citation>Biobot Analytics. Data on COVID-19 and Mpox wastewater monitoring. Accessed March 27, 2024. https://biobot.io/data/</Citation></Reference><Reference><Citation>De Salazar PM, Link NB, Lamarca K, Santillana M. High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in long-term care facilities. Commun Med (Lond). 2021;1:16. doi:10.1038/s43856-021-00015-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-021-00015-1</ArticleId><ArticleId IdType="pmc">PMC9053242</ArticleId><ArticleId IdType="pubmed">35602197</ArticleId></ArticleIdList></Reference><Reference><Citation>McDowall D, McCleary R, Bartos BJ. Interrupted Time Series Analysis. Oxford University Press. October 2019. Accessed March 27, 2024. https://global.oup.com/academic/product/interrupted-time-series-analysis-9780190943943?cc=us&amp;lang=en&amp;</Citation></Reference><Reference><Citation>Kogan NE, Clemente L, Liautaud P, et al. . An early warning approach to monitor COVID-19 activity with multiple digital traces in near real time. Sci Adv. 2021;7(10):eabd6989. doi:10.1126/sciadv.abd6989</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd6989</ArticleId><ArticleId IdType="pmc">PMC7935356</ArticleId><ArticleId IdType="pubmed">33674304</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong C, Hu S, Yang M, Luo W, Zhang L. Mobile device data reveal the dynamics in a positive relationship between human mobility and COVID-19 infections. Proc Natl Acad Sci U S A. 2020;117(44):27087-27089. doi:10.1073/pnas.2010836117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010836117</ArticleId><ArticleId IdType="pmc">PMC7959523</ArticleId><ArticleId IdType="pubmed">33060300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinazzi M, Davis JT, Ajelli M, et al. . The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395-400. doi:10.1126/science.aba9757</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aba9757</ArticleId><ArticleId IdType="pmc">PMC7164386</ArticleId><ArticleId IdType="pubmed">32144116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai S, Ruktanonchai NW, Zhou L, et al. . Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature. 2020;585(7825):410-413. doi:10.1038/s41586-020-2293-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2293-x</ArticleId><ArticleId IdType="pmc">PMC7116778</ArticleId><ArticleId IdType="pubmed">32365354</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Keshet A, Graham MS, et al. . Anosmia, ageusia, and other COVID-19–like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study. Lancet Digit Health. 2021;3(9):e577-e586. doi:10.1016/S2589-7500(21)00115-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(21)00115-1</ArticleId><ArticleId IdType="pmc">PMC8297994</ArticleId><ArticleId IdType="pubmed">34305035</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotta D, Grow A, Rampazzo F, et al. . Behaviours and attitudes in response to the COVID-19 pandemic: insights from a cross-national Facebook survey. EPJ Data Sci. 2021;10(1):17. doi:10.1140/epjds/s13688-021-00270-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1140/epjds/s13688-021-00270-1</ArticleId><ArticleId IdType="pmc">PMC8050509</ArticleId><ArticleId IdType="pubmed">33880320</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell J. Estimating COVID-19 prevalence in symptomatic Americans. Gallup Blog. April 3, 2020. Accessed August 19, 2024. https://news.gallup.com/opinion/gallup/306458/estimating-covid-prevalence-symptomatic-americans.aspx</Citation></Reference><Reference><Citation>Qasmieh SA, Robertson MM, Teasdale CA, Kulkarni SG, Nash D. Estimating the period prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the Omicron (BA.1) surge in New York City (NYC), 1 January to 16 March 2022. Clin Infect Dis. 2023;76(3):e499-e502. doi:10.1093/cid/ciac644</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac644</ArticleId><ArticleId IdType="pmc">PMC9384757</ArticleId><ArticleId IdType="pubmed">35959571</ArticleId></ArticleIdList></Reference><Reference><Citation>Rader B, Gertz A, Iuliano AD, et al. Use of at-home COVID-19 tests—United States, August 23, 2021–March 12, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(13):489-494. doi:10.15585/mmwr.mm7113e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7113e1</ArticleId><ArticleId IdType="pmc">PMC8979595</ArticleId><ArticleId IdType="pubmed">35358168</ArticleId></ArticleIdList></Reference><Reference><Citation>Qasmieh SA, Robertson MM, Teasdale CA, et al. . The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022. Commun Med (Lond). 2023;3(1):92. doi:10.1038/s43856-023-00321-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-023-00321-w</ArticleId><ArticleId IdType="pmc">PMC10313770</ArticleId><ArticleId IdType="pubmed">37391483</ArticleId></ArticleIdList></Reference><Reference><Citation>Outbreaks Near Me. Home. Accessed August 31, 2023. https://outbreaksnearme.org/us/en-US</Citation></Reference><Reference><Citation>Data For Good at Meta. COVID-19 trends and impact survey. Accessed November 21, 2023. https://dataforgood.facebook.com/dfg/tools/covid-19-trends-and-impact-survey</Citation></Reference><Reference><Citation>Smolinski MS, Crawley AW, Baltrusaitis K, et al. . Flu Near You: crowdsourced symptom reporting spanning 2 influenza seasons. Am J Public Health. 2015;105(10):2124-2130. doi:10.2105/AJPH.2015.302696</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2015.302696</ArticleId><ArticleId IdType="pmc">PMC4566540</ArticleId><ArticleId IdType="pubmed">26270299</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltrusaitis K, Santillana M, Crawley AW, Chunara R, Smolinski M, Brownstein JS. Determinants of participants’ follow-up and characterization of representativeness in Flu Near You, a participatory disease surveillance system. JMIR Public Health Surveill. 2017;3(2):e18. doi:10.2196/publichealth.7304</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/publichealth.7304</ArticleId><ArticleId IdType="pmc">PMC5400887</ArticleId><ArticleId IdType="pubmed">28389417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansolabehere S, Luks S, Schaffner BF. The perils of cherry picking low frequency events in large sample surveys. Elect Stud. 2015;40:409-410. doi:10.1016/j.electstud.2015.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.electstud.2015.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley VC, Kuriwaki S, Isakov M, Sejdinovic D, Meng XL, Flaxman S. Unrepresentative big surveys significantly overestimated US vaccine uptake. Nature. 2021;600(7890):695-700. doi:10.1038/s41586-021-04198-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04198-4</ArticleId><ArticleId IdType="pmc">PMC8653636</ArticleId><ArticleId IdType="pubmed">34880504</ArticleId></ArticleIdList></Reference><Reference><Citation>MacInnis B, Krosnick JA, Ho AS, Cho MJ. The accuracy of measurements with probability and nonprobability survey samples: replication and extension. Public Opin Q. 2018;82(4):707-744. doi:10.1093/poq/nfy038</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/poq/nfy038</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinton J, Cohen J, Lapinski J, Trussler M. Partisan pandemic: how partisanship and public health concerns affect individuals’ social mobility during COVID-19. Sci Adv. 2021;7(2):eabd7204. doi:10.1126/sciadv.abd7204</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd7204</ArticleId><ArticleId IdType="pmc">PMC7787499</ArticleId><ArticleId IdType="pubmed">33310734</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>